ARCHIVES

In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List

This article is from The Cancer Letter archive.

Vol. 09 No. 46 | December 2, 1983

Download PDF Visit The Full Archive

Related Articles

Program Announcement listed.

July 25, 2003

In Brief: san Antonio’s ICRC Gets a New Name, SACI; Blum Is deputy Oncology Director At Kaplan

May 14, 1993

Obesity, Faster Weight Gain, Linked To Poor Prognosis

October 28, 2005

Univ. of Rochester Leads Trial Of Combination Chemotherapy For Pancreatic Cancer

November 29, 2002

In Brief: Takeo Kakanaga Dies; President’s Cancer Panel to Meet Nov. 7; Young To Give Schwartz Lecture

October 7, 1988

Evidence Lacking On Value of Vitamins to Prevent Disease, Panel Says.

June 16, 2006